Journal News

New chemical strategy boosts accuracy in proteomics

Vanshika Patel
Nov. 6, 2025

Overlabeling of peptides in proteomics mass spectrometry reduces protein identification and quantitation precision. In proteomics sample preparation, a chemical called N-hydroxysuccinimide, or NHS, is commonly used in tagging proteins to identify proteins for quantitation. However, NHS can also react with other amino acid residues, forming unwanted O-ester derivatives, which bond to oxygen atoms of amino acids such as serine, tyrosine and threonine, complicating analysis. While existing methods, such as hydroxylamine treatment, have been used to reduce excess NHS esters, it is not fully effective, and scientists lack methods to sufficiently remove overlabeled peptides.

Yana Demyanenko and a team of researchers based in the U.K. and Germany published an article in Molecular & Cellular Proteomics, where they developed a methylamine-based method to remove these O-ester modifications. They found that methylamine was the most effective in reducing overlabeled peptides among various tested reagents, such as hydroxylamine, O-methoxylamine HCl, hydrazine hydrate, Tris and ammonium hydroxide. In contrast, standard labeling without quenching led to over 25% overlabeled peptides, while hydroxylamine treatment reduced this to only 10%. Methylamine, however, reduced the overlabeling to less than 1% without affecting the labeling rate or causing additional modifications. Future research will apply this methylamine-based approach to different proteomics workflows to improve peptide identification and quantitation.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Vanshika Patel

Vanshika Patel is a Ph.D. candidate in the pharmaceutical sciences department at the University of Maryland, Baltimore. She studies vitamin A signaling and the ERK 1/2 pathway in asthma in the Kane lab. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Defining JNKs: Targets for drug discovery
Award

Defining JNKs: Targets for drug discovery

Feb. 12, 2026

Roger Davis will receive the Bert and Natalie Vallee Award in Biomedical Science at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Building better tools to decipher the lipidome
Profile

Building better tools to decipher the lipidome

Feb. 11, 2026

Chemical engineer–turned–biophysicist Matthew Mitsche uses curiosity, coding and creativity to tackle lipid biology, uncovering PNPLA3’s role in fatty liver disease and advancing mass spectrometry tools for studying complex lipid systems.

Redefining lipid biology from droplets to ferroptosis
Award

Redefining lipid biology from droplets to ferroptosis

Feb. 5, 2026

James Olzmann will receive the ASBMB Avanti Award in Lipids at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Women’s health cannot leave rare diseases behind
Essay

Women’s health cannot leave rare diseases behind

Feb. 4, 2026

A physician living with lymphangioleiomyomatosis and a basic scientist explain why patient-driven, trial-ready research is essential to turning momentum into meaningful progress.

Life in four dimensions: When biology outpaces the brain
Profile

Life in four dimensions: When biology outpaces the brain

Jan. 27, 2026

Nobel laureate Eric Betzig will discuss his research on information transfer in biology from proteins to organisms at the 2026 ASBMB Annual Meeting.

Fasting, fat and the molecular switches that keep us alive
Interview

Fasting, fat and the molecular switches that keep us alive

Jan. 27, 2026

Nutritional biochemist and JLR AE Sander Kersten has spent decades uncovering how the body adapts to fasting. His discoveries on lipid metabolism and gene regulation reveal how our ancient survival mechanisms may hold keys to modern metabolic health.